Article, 2023

A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

SCIENCE TRANSLATIONAL MEDICINE, ISSN 1946-6234, Volume 15, 695, 10.1126/scitranslmed.abp9229

Contributors

IG 0000-0002-1360-348X [1] [2] [3] [4] [5] Tanos, Tamara [6] Bustamante, Mariana [1] [6] Sanmamed, M. F. 0000-0002-7295-6074 [1] [2] [3] [4] Calvo, E. 0000-0003-4921-829X [5] Moreno, Irene GARCIA, VICTOR G. 0000-0002-1849-8834 [7] Hernandez, Tatiana [7] [8] Martinez-Garcia, Maria 0000-0001-5891-3935 [3] [4] [9] [10] Rodriguez-Vida, Alejo 0000-0002-7304-6857 [3] [4] [9] [10] Tabernero, Josep 0000-0002-2495-8139 [2] [3] [4] [11] [12] Azaro, A. [11] [12] Ponz-Sarvise, Mariano Spanggaard, Iben [13] [14] Rohrberg, Kristoffer [13] [14] Guarin, Ernesto Nueesch, Eveline [15] Davydov, Iakov Ooi, Chiahuey Duarte, Jose 0000-0003-2610-9795 Chesne, Evelyne [6] McIntyre, C. [16] Ceppi, Maurizio [6] [17] Canamero, Marta 0000-0003-2239-4285 [18] Krieter, Oliver (Corresponding author) [18]

Affiliations

  1. [1] Clin Univ Navarra, Dept Immunol & Immunotherapy, CIMA, Pamplona 31008, Spain
    2. [NORA names: Spain; Europe, EU; OECD];
  2. [2] Inst Salud Carlos III, CIBERONC, Madrid 28029, Spain
    3. [NORA names: Spain; Europe, EU; OECD];
  3. [3] Hosp Mar, Dept Med Oncol, CIBERONC, Barcelona 08003, Spain
    4. [NORA names: Spain; Europe, EU; OECD];
  4. [4] Hosp Mar, Dept Med Oncol, CIBERONC, Barcelona 08003, Spain
    5. [NORA names: Spain; Europe, EU; OECD];
  5. [5] Ctr Integral Oncol Clara Campal, START Madrid CIOCC, Madrid 28050, Spain
    6. [NORA names: Spain; Europe, EU; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+